← Eichor
Study identifier: NCT04684602 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Condition: Autoimmune Diseases · Cardiovascular Disorders · Diabetes Complications  ·  Sponsor: Thomas Advanced Medical LLC

PhasePhase 1/Phase 2
Planned participants5000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

This description comes directly from the study's public registry record.

Talk to the study team

Paul C Bogaardt, PhD(c), MSc, MBA  ·  866 864 7789  ·  paul@thomasadvancedmedical.com

Karen Mulholland Angelus  ·  866 864 7789  ·  karen@thomasadvancedmedical.com

Always discuss trial participation with your own doctor first.

Locations (1)

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator SitesCulver City, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04684602